Interaction of calpastatin with calpain: A review

Biological Chemistry

Volumn 385, Issue 6, 2004, Pages 465-472

  Wendt, Amanda ^a   Thompson, Valery F ^a   Goll, Darrel E ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Binding; Calcium; Inhibitor; Proteases; Structure

Indexed keywords

AMINO ACID; CALPAIN; CALPASTATIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BINDING SITE; CRYSTALLOGRAPHY; HUMAN; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS;

ANIMALS; BINDING SITES; CALCIUM-BINDING PROTEINS; CALPAIN; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 3242798339     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2004.054     Document Type: Review

References (46)

1. Betts, R., Weinsheimer, S., Blouse, G.E., and Anagli, J. (2003). Structural determinants of the calpain inhibitory activity of calpastatin peptide B27-WT. J. Biol. Chem. 278, 7800-7809.
2. Cong, M., Thompson, V.F., Goll, D.E., and Antin, P.B. (1998). The bovine calpastatin gene promoter and a new N-terminal region of the protein are targets for cAMP dependent protein kinase activity. J. Biol. Chem. 273, 660-666.
3. Crawford, C., Brown, N.R., and Willis, A.C. (1993). Studies of the active site of m-calpain and the interaction with calpastatin. Biochem. J. 296, 135-142.
4. Croall, D.E., and McGrody, K.S. (1994). Domain structure of calpain: mapping the binding site for calpastatin. Biochemistry 33, 13223-13230.
5. 2+-activated protease possibly involved in myofibrillar protein turnover. Purification from porcine muscle. Biochemistry 15, 2150-2158.
6. Emori, Y, Kawasaki, H., Imajoh, S., Imahori, K., and Suzuki, K. (1987). Endogenous inhibitor for calcium-dependent cysteine protease contains four internal repeats that could be responsible for its multiple reactive sites. Proc. Natl. Acad. Sci. 84, 3590-3594.
7. Emori, Y., Kawasaki, H., Imajoh, S., Minami, Y., and Suzuki, K. (1988). All four repeating domains of the endogenous inhibitor for calcium-dependent protease independently retain inhibitory activity. Expression of the cDNA fragments in Escherichia coli. J. Biol. Chem. 263, 2364-2370.
8. Goll, D.E., Thompson, V.F., Li, H., Wei, W., and Cong, J. (2003). The calpain system. Physiol. Rev. 83, 731-801.
9. Imajoh, S., Kawasaki, H., Emori, Y., Ishiura, S., Minami, Y., Sugita, H., Imahori, K., and Suzuki, K. (1987a). A fragment of an endogenous inhibitor produced in Escherichia coli for calcium-activated neutral protease (CANP) retains an inhibitory activity. FEBS Lett. 215, 274-278.
10. Imajoh, S., Kawasaki, H., Emori, Y., and Suzuki, K. (1987b). Calcium-activated neutral protease inhibitor from rabbit erythrocytes lacks the N-terminal region of the liver inhibitor but retains three inhibitory units. Biochem. Biophys. Res. Comm. 146, 630-637.
11. Imajoh, S., Kawasaki, H., Kisaragi, M., Mukai, M., Sugita, H., and Suzuki, K. (1984). A 107-kDa inhibitor for calcium-activated neutral protease (CANP): purification from the human liver. Biomed. Res. 5, 481-488.
12. 2+-activated neutral protease (CANP) and its endogenous inhibitor. FEBS Lett. 187, 47-50.
13. Ishima, R., Tamura, A., Akasaka, K., Hamaguchi, K., Makino, K., Murachi, T., Hatanaka, M., and Maki, M. (1991). Structure of the active 27-residue fragment of human calpastatin. FEBS Lett. 294, 64-66.
14. 2+ on binding of the calpains to calpastatin. J. Biol. Chem. 264, 17888-17896.
15. Kawasaki, H., Emori, Y., Imajoh-Ohmi, S., Minami, Y., and Suzuki, K. (1989). Identification and characterization of inhibitory sequences in four repeating domains of the endogenous inhibitor for calcium-dependent protease. J. Biochem. 106, 274-281.
16. Konno, T., Tanaka, N., Kataoka, M., Takano, E., and Maki, M. (1997). A circular dichroism study of preferential hydration and alcohol effects on a denatured protein, pig calpastatin domain I. Biochim. Biophys. Acta 1342, 73-82.
17. Lee, W.J., Ma, H., Takano, E., Yang, H.Q., Hatanaka, M., and Maki, M. (1992). Molecular diversity in amino-terminal domains of human calpastatin by exon skipping. J. Biol. Chem. 267, 8437-8442.
18. Lepley, R.A., Pampusch, M., and Dayton, W.R. (1985). Purification of a high-molecular-weight inhibitor of the calcium-activated proteinase. Biochim. Biophys. Acta 828, 95-103.
19. Ma, H., Yang, H.Q., Takano, E., Hatanaka, M., and Maki, M. (1994). Amino-terminal conserved region in proteinase inhibitor domain of calpastatin potentiates its calpain inhibitory activity by interacting with the calmodulin-like domain of the proteinase. J. Biol. Chem. 269, 24430-24436.
20. Ma, H., Yang, H.Q., Takano, E., Lee, W.J., Hatanaka, M., and Maki, M. (1993). Requirement of different subdomains of calpastatin for calpain inhibition and for binding to calmodulin-like domains. J. Biochem. 113, 591-599.
21. Maki, M., Takano, E., Mori, H., Kannagi, R., Murachi, T., and Hatanaka, M. (1987a). Repetitive region of calpastatin is a functional unit of the proteinase inhibitor. Biochem. Biophys. Res. Comm. 143, 300-308.
22. Maki, M., Takano, E., Mori, H., Sato, A., Murachi, T., and Hatanaka, M. (1987b). All four internally repetitive domains of pig calpastatin possess inhibitory activities against calpains I and II. FEBS Lett. 223, 174-180.
23. Maki, M., Takano, E., Osawa, T., Ooi, T., Murachi, T., and Hatanaka, M. (1988). Analysis of structure-function relationship of pig calpastatin by expression of mutated cDNAs in Escherichia coli. J. Biol. Chem. 263, 10254-10261.
24. Maki, M., Baǧci, H., Hamaguchi, K., Ueda, M., Murachi, T., and Hatanaka, M. (1989). Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. J. Biol. Chem. 264, 18866-18869.
25. Maki, M., Ma, H., Takano, E., Adachi, Y., Lee, W.J., Hatanaka, M., and Murachi, T. (1991). Calpastatins: biochemical and molecular biological studies. Biomed. Biochim. Acta 50, 509-516.
26. Mellgren R.L., and Carr, T.C. (1983). The protein inhibitor of calcium-dependent proteases: purification from bovine heart and possible mechanisms of regulation. Arch. Biochem. Biophys. 225, 779-786.
27. Mohan, P.S., and Nixon, R.A. (1995). Purification and properties of high molecular weight calpastatin from bovine brain. J. Neurochem. 64, 859-866.
28. Mucsi, Z., Hudecz, F., Hollósi, M., Tompa, P., and Friedrich, P. (2003). Binding-induced folding transitions in calpastatin subdomains A and C. Protein Sci. 12, 2327-2336.
29. Murachi, T. (1989). Intracellular regulatory system involving calpain and calpastatin. Biochem. Int. 18, 263-294.
30. Nakamura, M., Inomata, M., Hayashi, M., Imahori, K., and Kawashima, S. (1984). Purification and characterization of an inhibitor of calcium-activated neutral protease from rabbit skeletal muscle: purification of 50,000 dalton inhibitor. J. Biochem. 96, 1399-1407.
31. Nishimura, T., and Goll, D.E. (1991). Binding of calpain fragments to calpastatin. J. Biol. Chem. 266, 11842-11850.
32. 2+-activated protease involved in myofibrillar protein turnover. Federation Proc. 35, 1746.
33. 2+-dependent proteinase. J. Biol. Chem. 262, 5839-5851.
34. Parr, T., Sensky, P.L., Bardsley, R.G., and Buttery, P.J. (2001). Calpastatin expression in porcine cardiac and skeletal muscle and partial gene structure. Arch. Biochem. Biophys. 395, 1-13.
35. Reverter, D. Sorimachi, H., and Bode, W. (2001). The structure of calcium-free human m-calpain. Implications for calcium activation and function. Trends Cardiovasc. Med. 11, 222-229.
36. 2+-dependent proteinase. In: Intracellular Protein Catabolism, E.A. Khairallah, J.S. Bond, and J.W.S. Bird, eds. (New York, USA: Alan R. Liss, Inc.), pp. 257-259.
37. Takano, E., Ma, H., Yang, H.Q., Maki, M., and Hatanaka, M. (1995). Preference of calcium-dependent interactions between calmodulin-like domains of calpain and calpastatin subdomains. FEBS Lett. 362, 93-97.
38. Takano, E., Maki, M., Mori, H., Hatanaka, M., Marti, T., Titani, K., Kannagi, R., Ooi, T., and Murachi, T. (1988). Pig heart calpastatin: identification of repetitive domain structures and anomalous behavior in polyacrylamide gel electrophoresis. Biochemistry 27, 1964-1972.
39. Takano, E., and Murachi, T. (1982). Purification and some properties of human erythrocyte calpastatin. J. Biochem. 92, 2021-2028.
40. Takano, J., Kawamura, T., Murase, M., Hitomi, K., and Maki, M. (1999). Structure of mouse calpastatin isoforms: implications of species-common and species-specific alternative splicing. Biochem. Biophys. Res. Commun. 260, 339-345.
41. Takano, J., Watanabe, M., Hitomi, K., and Maki, M. (2000). Four types of calpastatin isoforms with distinct amino-terminal sequences are specified by alternative first exons and differentially expressed in mouse tissues. J. Biochem. 128, 83-92.
42. Todd, B., Moore, D., Deivanayagam, C.C.S., Lin, G-d., Chattopadhyay, D., Maki, M., Wang, K.K.W., and Narayana, S.V.L. (2003). A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor. J. Mol. Biol. 328, 131-146.
43. Uemori, T., Shimojo, T., Asada, K., Asano, T., Kimizuka, F., Kato, I., Maki, M., Hatanaka, M., Murachi, T., Hanzawa, H., and Arata, Y. (1990). Characterization of a functional domain of human calpastatin. Biochem. Biophys. Res. Commun. 166, 1485-1493.
44. Wang, K.K.W., Nath, R., Posner, A., Raser, K.J., Buroker-Kilgore, M., Hajimohammadreza, I., Probert, A.W., Jr., Marcoux, F.W., Ye, Q., Takano, E., Hatanaka, M. et al. (1996). An α-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. Proc. Natl. Acad. Sci. USA 93, 6687-6692.
45. Wang, L.F., Wei, S.G., Miao, S.Y., Liu, Q.Y., and Koide, S.S. (1994). Calpastatin gene in human testis. Biochem. Mol. Biol. Int. 33, 245-251.
46. Yang, H.Q., Ma, H., Takano, E., Hatanaka, M., and Maki, M. (1994). Analysis of calcium-dependent interaction between amino-terminal conserved region of calpastatin functional domain and calmodulin-like domain of μ-calpain large subunit. J. Biol. Chem. 269, 18977-18984.